Condensed Consolidated Statements of Stockholders' Deficit - USD ($) shares in Thousands, $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss		Retained Earnings	Treasury Stock		Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 25, 2022			34,736
Beginning balance at Dec. 25, 2022		$ (270,664)	$ 491	$ 449,829	$ (10,135)	[1]	$ 195,856	$ (922,434)	[2]	$ 15,729
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3]	56,221					56,005			216
Other comprehensive income (loss), net of tax		2,219			2,219	[1]
Dividends on common stock		(43,641)		88			(43,729)
Exercise of stock options (in shares)			35
Exercise of stock options		$ 1,817	$ 1	1,816
Acquisition of Company common stock (in shares)		(2,523)	(2,523)
Acquisition of Company common stock		$ (212,444)						(212,444)	[2]
Stock-based compensation expense		13,224		13,224
Issuance of restricted stock (in shares)			234
Issuance of restricted stock		0		(6,857)				6,857	[2]
Tax effect of restricted stock awards (in shares)			(75)
Tax effect of restricted stock awards		(6,279)		(6,279)
Distributions to noncontrolling interests		(651)								(651)
Other (in shares)			66
Other		300		(4,122)				4,422	[2]
Ending balance (in shares) at Sep. 24, 2023			32,473
Ending balance at Sep. 24, 2023		(459,898)	$ 492	447,699	(7,916)	[1]	208,132	(1,123,599)	[2]	15,294
Beginning balance (in shares) at Jun. 25, 2023			32,394
Beginning balance at Jun. 25, 2023		(465,479)	$ 492	445,964	(7,289)	[1]	207,461	(1,127,669)	[2]	15,562
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[3]	15,921					15,861			60
Other comprehensive income (loss), net of tax		(627)			(627)	[1]
Dividends on common stock		(15,156)		34			(15,190)
Exercise of stock options (in shares)			18
Exercise of stock options		$ 1,134		1,134
Acquisition of Company common stock (in shares)		0
Stock-based compensation expense		$ 4,726		4,726
Issuance of restricted stock (in shares)			7
Issuance of restricted stock		0		(315)				315	[2]
Tax effect of restricted stock awards (in shares)			(2)
Tax effect of restricted stock awards		(171)		(171)
Distributions to noncontrolling interests		(328)								(328)
Other (in shares)			56
Other		82		(3,673)				3,755	[2]
Ending balance (in shares) at Sep. 24, 2023			32,473
Ending balance at Sep. 24, 2023		$ (459,898)	$ 492	447,699	(7,916)	[1]	208,132	(1,123,599)	[2]	15,294
Beginning balance (in shares) at Dec. 31, 2023		32,500	32,488
Beginning balance at Dec. 31, 2023		$ (443,616)	$ 492	452,290	(7,803)	[4]	219,027	(1,123,098)		15,476
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[5]	69,005					68,687			318
Other comprehensive income (loss), net of tax		1,223			1,223	[4]
Dividends on common stock		(45,350)		95			(45,445)
Exercise of stock options (in shares)			22
Exercise of stock options		$ 1,021	$ 1	1,020
Acquisition of Company common stock (in shares)		0
Stock-based compensation expense		$ 5,903		5,903
Issuance of restricted stock (in shares)			171
Issuance of restricted stock		0		(6,242)				6,242
Tax effect of restricted stock awards (in shares)			(52)
Tax effect of restricted stock awards		(3,508)		(3,508)
Distributions to noncontrolling interests		(480)								(480)
Other (in shares)			8
Other		$ 183		(417)				600
Ending balance (in shares) at Sep. 29, 2024		32,600	32,637
Ending balance at Sep. 29, 2024		$ (415,619)	$ 493	449,141	(6,580)	[4]	242,269	(1,116,256)		15,314
Beginning balance (in shares) at Jun. 30, 2024			32,622
Beginning balance at Jun. 30, 2024		(446,140)	$ 493	446,547	(7,358)	[4]	215,800	(1,117,140)		15,518
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[5]	41,745					41,808			(63)
Other comprehensive income (loss), net of tax		778			778	[4]
Dividends on common stock		(15,308)		31			(15,339)
Exercise of stock options (in shares)			2
Exercise of stock options		$ 88		88
Acquisition of Company common stock (in shares)		0
Stock-based compensation expense		$ 3,358		3,358
Issuance of restricted stock (in shares)			14
Issuance of restricted stock		0		(632)				632
Tax effect of restricted stock awards (in shares)			(4)
Tax effect of restricted stock awards		(178)		(178)
Distributions to noncontrolling interests		(141)								(141)
Other (in shares)			3
Other		$ 179		(73)				252
Ending balance (in shares) at Sep. 29, 2024		32,600	32,637
Ending balance at Sep. 29, 2024		$ (415,619)	$ 493	$ 449,141	$ (6,580)	[4]	$ 242,269	$ (1,116,256)		$ 15,314

[1] At September 24, 2023, the accumulated other comprehensive loss of $7,916 was comprised of net unrealized foreign currency translation loss of $8,702 and net unrealized gain on the interest rate swap agreements of $786.

[2] Acquisition of Company common stock for the nine months ended September 24, 2023, includes $2,804 of transaction costs directly attributable to share repurchases, including a 1% excise tax incurred under the Inflation Reduction Act of 2022.

[3] Net income to the Company for the three and nine months ended September 24, 2023 excludes $30 and $135, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.

[4] At September 29, 2024, the accumulated other comprehensive loss of $6,580 was comprised of net unrealized foreign currency translation loss of $6,186 and net unrealized loss on the interest rate swap agreements of $394.

[5] Net income to the Company for the three and nine months ended September 29, 2024 excludes $43 and $233, respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.